Acquiring Company
Artivion
Acquired Company
Endospan
Kennesaw
Tel Aviv DistrictManufacturingBiotechnologyHealthcareHealth CareMedicalMedical DeviceBiotechnologyHealth CareMedical DeviceDescription
Artivion is set to acquire full ownership of Endospan for approximately $135 million, with potential additional payments of up to $200 million. This acquisition follows FDA approval of Endospan’s Nexus system for aortic arch treatments. The transaction will be completed in cash and is subject to customary closing conditions.
Quick answer
Artivion is acquiring Endospan for $335 million, announced May 18, 2026. Artivion is based in Kennesaw, Georgia, United States.
- How much did Artivion pay for Endospan?
- The reported deal value is $335 million.
- What does Artivion do?
- Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating..
- Where are Artivion and Endospan based?
- Artivion is based in Kennesaw, Georgia, United States. Endospan is based in Tel Aviv District, Israel.
- Who are the decision-makers at Artivion?
- Fundz holds 1 contact at Artivion. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Medtronic to acquire SPR Therapeutics for chronic pain care (May 20, 2026)
- Alkem Medtech to acquire majority stake in Occlutech (June 29, 2026)
- Everis Medical acquires Hood Laboratories for growth (May 20, 2026)
- AP Technologies acquires Blueacre Technology for growth (May 19, 2026)
- Artivion, Inc. Completes Acquisition of Endospan Ltd. (May 18, 2026)
- Advanced Bifurcation Systems Acquires Svelte Medical (April 27, 2026)
Who to call at Artivion, and when
When Artivion changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Artivion raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Artivion, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Artivion. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Artivion makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Endospan?
Endospan was acquired by Artivion, based in Kennesaw. The deal was reported on May 18, 2026. Headquartered in suburban Atlanta, Georgia, Artivion, Inc. Artivion is publicly traded (AORT) and operates in Manufacturing.
When did Artivion acquire Endospan?
Artivion's acquisition of Endospan was reported on May 18, 2026. Artivion is set to acquire full ownership of Endospan for approximately $135 million, with potential additional payments of up to $200 million. This acquisition follows FDA approval of Endospan’s Nexus system for aortic arch treatments. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Endospan do?
Endospan is a pioneer in endovascular solutions for aortic arch disease, specializing in the repair of aneurysms and dissections. It is privately held, operating in Biotechnology, and is based in Tel Aviv District.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.